Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.
Nadine EzardAdrian DunlopBrendan CliffordRaimondo BrunoAndrew CarrAlexandra BissakerNicholas LintzerisPublished in: BMC psychiatry (2016)
Australian and New Zealand Clinical Trials Registry ACTRN12615000391572 Registered 28th April 2015.